Targeting SUMO2 reverses aberrant epigenetic rewiring driven by SS18::SSX fusion oncoproteins and impairs sarcomagenesis [ChIP-seq]
Ontology highlight
ABSTRACT: Targeting SUMO2 reverses aberrant epigenetic rewiring driven by SS18::SSX fusion oncoproteins and impairs sarcomagenesis [ChIP-seq]
PROVIDER: PRJNA1154633 | ENA |
REPOSITORIES: ENA
ACCESS DATA